Roche Holding AG (OTCQX International Premier:RHHBF)

255.36
Delayed Data
As of 11:13am ET
 +2.95 / +1.17%
Today’s Change
214.46
Today|||52-Week Range
262.56
+2.02%
Year-to-Date
Roche to Create Companion Diagnostic Test for Merck's Keytruda
9:30am / Zacks.com - Paid Partner Content
AbbVie Halts Rova-T Phase III Second-Line Lung Cancer Study
Dec 06 / Zacks.com - Paid Partner Content
Gilead Sciences (GILD) Appoints Daniel O'Day as New CEO
Dec 11 / Zacks.com - Paid Partner Content
Exelixis Initiates Pivotal Liver Cancer Study on Cabometyx
Dec 06 / Zacks.com - Paid Partner Content
Roche's Tecentriq Gets FDA Approval for First-Line NSCLC
Dec 10 / Zacks.com - Paid Partner Content
J&J's Blood Cancer Drugs Succeed in Label Expansion Studies
Dec 05 / Zacks.com - Paid Partner Content
Amgen (AMGN) Continues to Reward Shareholders, Ups Dividend
Dec 10 / Zacks.com - Paid Partner Content
Roche's Tecentriq Combination Gets Priority Review by FDA
Dec 05 / Zacks.com - Paid Partner Content
Roche's Kadcyla Halves Death Risk in Breast Cancer Study
Dec 06 / Zacks.com - Paid Partner Content
Roche Announces Positive Data on Venclexta/Venclyxto at ASH
Dec 04 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close252.41
Today’s open255.36
Day’s range255.36 - 255.36
Volume16
Average volume (3 months)362
Market cap$39.4B
Data as of 11:13am ET, 12/12/2018

Growth & Valuation

Earnings growth (last year)-9.88%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+5.48%
P/E ratio19.7
Price/Sales4.01
Price/Book7.74

Competitors

No competitors data available.

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$54.2B
Annual profit (last year)$8.8B
Net profit margin16.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Severin Schwan
Chief Financial &
Information Technology Officer
Alan Hippe
Corporate headquarters
Basel, Basel-stadt (basle Town)

Forecasts